A detailed history of Israel Englander (Millennium Management LLC) transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 782,299 shares of ORIC stock, worth $8.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
782,299
Previous 196,852 297.4%
Holding current value
$8.06 Million
Previous $2.71 Million 104.36%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.63 - $12.93 $3.88 Million - $7.57 Million
585,447 Added 297.4%
782,299 $5.53 Million
Q1 2024

May 15, 2024

BUY
$8.04 - $16.03 $1.58 Million - $3.16 Million
196,852 New
196,852 $2.71 Million
Q2 2023

Aug 14, 2023

SELL
$4.95 - $8.4 $5.5 Million - $9.34 Million
-1,111,532 Reduced 49.02%
1,156,110 $8.97 Million
Q1 2023

May 15, 2023

BUY
$4.26 - $6.75 $1.63 Million - $2.59 Million
383,664 Added 20.36%
2,267,642 $12.9 Million
Q4 2022

Feb 14, 2023

BUY
$2.41 - $5.89 $856,441 - $2.09 Million
355,370 Added 23.25%
1,883,978 $11.1 Million
Q3 2022

Nov 14, 2022

BUY
$3.15 - $5.24 $272,887 - $453,946
86,631 Added 6.01%
1,528,608 $4.89 Million
Q2 2022

Aug 15, 2022

BUY
$2.7 - $7.07 $2.87 Million - $7.53 Million
1,064,486 Added 281.99%
1,441,977 $6.46 Million
Q1 2022

May 16, 2022

BUY
$4.54 - $16.1 $1.71 Million - $6.08 Million
377,491 New
377,491 $2.02 Million
Q3 2021

Nov 15, 2021

SELL
$15.9 - $25.22 $3.69 Million - $5.85 Million
-231,853 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$17.37 - $25.34 $1.88 Million - $2.75 Million
108,396 Added 87.8%
231,853 $4.1 Million
Q1 2021

May 17, 2021

BUY
$23.67 - $36.85 $511,153 - $795,775
21,595 Added 21.2%
123,457 $3.03 Million
Q4 2020

Feb 16, 2021

BUY
$20.32 - $39.8 $1.57 Million - $3.08 Million
77,372 Added 315.93%
101,862 $3.45 Million
Q3 2020

Nov 16, 2020

BUY
$19.5 - $31.26 $477,555 - $765,557
24,490 New
24,490 $612,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $408M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.